We are live on ! Find out more
VCYT icon

Veracyte

64 hedge funds and large institutions have $110M invested in Veracyte in 2015 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 26 increasing their positions, 16 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 4

63% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 16

49% more capital invested

Capital invested by funds: $73.5M → $110M (+$36.2M)

5% more funds holding

Funds holding: 6164 (+3)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $170K

Holders
64
Holders Change
+3
Holders Change %
+4.92%
% of All Funds
1.68%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
7
Increased
26
Reduced
16
Closed
4
Calls
Puts
$170K
Net Calls
-$170K
Net Calls Change
-$170K

VCYT Hedge Fund Activity: Q4 2015 in Review

64 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Veracyte (VCYT) for Q4 2015, worth a combined $110M — up 49% from $73.5M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new VCYT positions and 4 closed out — a net gain of 3 holders — while 26 added to existing stakes and 16 trimmed.

The largest buyer was Acuta Capital Partners, adding an estimated $5.46M. The largest seller was Camber Capital Management, exiting entirely with an estimated $4.27M sold.

  • 64 institutional investors held Veracyte (VCYT) as of Q4 2015, up from 61 in Q3 2015.
  • Funds reported $110M of Veracyte stock for Q4 2015, up 49% quarter-over-quarter.
  • 7 funds opened new Veracyte positions in Q4 2015 and 4 closed out, a net change of +3 holders.
  • The largest Veracyte buyer in Q4 2015 was Acuta Capital Partners, an estimated $5.46M added.
  • The largest Veracyte seller in Q4 2015 was Camber Capital Management, an estimated $4.27M sold.

Based on aggregated 13F filings for Q4 2015.